Search Results

Immunotoxicity Evaluation of Trihalophenolic Disinfection By-Products in Mouse and Human Mononuclear Macrophage Systems: The Role of RNA Epitranscriptomic Modification in Mammalian Immunity.

• Authors : Min Qin; Linyuan Huang; Meishuang Li

Subjects: RNA metabolism; Biomarkers; Escherichia coli

• Source: Environmental Health Perspectives. Dec2023, Vol. 131 Issue 12, p127023-1-127023-15. 15p.

Record details

Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A.

• Authors : Ya-Ping Song; Jin-Wei Lv; Zhi-Cheng Zhang

Subjects: Maternal exposure; Biochemistry; In vitro studies

• Source: Environmental Health Perspectives. Sep2023, Vol. 131 Issue 9, p097004-1-097004-19. 19p. 7 Color Photographs, 1 Diagram, 2 Charts.

Record details

Metabolism of Low-Dose Inorganic Arsenic in a Central European Population: Influence of Sex and Genetic Polymorphisms.

• Authors : Lindberg, Anna-Lena; Kumar, Rajiv; Goessler, Walter

Subjects: Physiological effects of arsenic; Methylation; Genetic polymorphismsRomania; Slovakia; Hungary

• Source: Environmental Health Perspectives. Jul2007, Vol. 115 Issue 7, p1081-1086. 6p. 1 Diagram, 4 Charts, 2 Graphs.

Record details

Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corp, to Develop Personalized Therapeutics for Genetically- Defined Cancers.

Subjects: Celgene International Sarl; Epizyme Inc.; Strategic alliances (Business)United States

• Source: Biomedical Market Newsletter. 4/28/2012, Vol. 21, p1-3. 3p.

Record details

New Screening Technique from Scripps Research Institute Yields Elusive Compounds to Block Immune-Regulating Enzyme.

Subjects: Scripps Research Institute; Enzyme inactivation; Asthma prevention

• Source: Biomedical Market Newsletter. 5/12/2012, Vol. 21, p1-3. 3p.

Record details

Leukemia & Lymphoma Society and Epizyme Announce Achievement of Pre-clinical Milestone in DOT1L Personalized Therapeutic Partnership.

Subjects: Epizyme Inc.; Research & development partnership; Individualized medicine

• Source: Biomedical Market Newsletter. 3/21/2012, Vol. 21, p1-3. 3p.

Record details

MDxHealth and Merck KGaA Extend Agreement for Use of MGMT Assay in Brain Cancer Clinical Trials.

Subjects: Business partnerships; MDxHealth SA; Merck KGaA

• Source: Biomedical Market Newsletter. 6/19/2011, p1265-1267. 3p.

Record details

Epizyme Achieves $4 Mln in Pre-Clinical Milestone Payments in GlaxoSmithKline Alliance to Discover and Develop Novel HMT Therapeutics.

Subjects: GlaxoSmithKline; Epizyme Inc.; Strategic alliances (Business)United States

• Source: Biomedical Market Newsletter. 10/17/2011, Vol. 21, p237-238. 2p.

Record details

Leukemia & Lymphoma Society and Epizyme Partner to Develop Personalized Therapeutic for Genetically-Defined Mixed Lineage Leukemia (MLL) Patients.

Subjects: Joint ventures; Epizyme Inc.; Cancer associationsUnited States

• Source: Biomedical Market Newsletter. 6/30/2011, p272-273. 2p.

Record details

Variation in COMT associated with duloxetine response.

Subjects: Therapeutics; Mental depression; Neurotransmitters

• Source: Brown University Psychopharmacology Update. Jul2009, Vol. 20 Issue 7, p7-7. 1/4p.

Record details